Development of Bacteriophages targeting strains causing urinary tract infections Establishment of collaboration with the US Army and investigation of groundwork for entering the US defense market BOSTON and SEOUL, South Korea, Sept. 3, 2023 /PRNewswire/ — iNtRON Biotechnology (“iNtRON”, www.intodeworld.com) has announced today that its New Drug Part has entered into an official contract with the U.S. … Read more
IND builds on previously-published, preliminary evidence of efficacy Filing is supported by robust manufacturing, pre-clinical and clinical data already reviewed by FDA for NRX-101 associated with treatment of bipolar depression RADNOR, Pa., Aug. 30, 2023 /PRNewswire/ – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced submission an Investigational New … Read more
WEST CHESTER, Pa., Aug. 28, 2023 /PRNewswire/ — In response to a significant global unmet need for the “SUTURE-TIGHT”™ catheter, VESTECK, Inc. is expanding the International Scientific Advisory Board. We are honored to have Professor Dainis Krievins, from Latvia, Canadian, Dr. Bao Bui and Australian, Professor Ramon Varcoe join the VESTECK Scientific Advisory Board. VESTECK … Read more
The FDA granted Aardvark Therapeutics a Rare Pediatric Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare genetic disease characterized by extreme and unabating hunger. Aardvark’s Phase 2 trial of oral ARD-101 in young adults with PWS is now open for enrollment of additional subjects. SAN DIEGO, Aug. 3, 2023 /PRNewswire/ — Aardvark Therapeutics, … Read more
SAN DIEGO, July 30, 2023 /PRNewswire/ — Synergy Orthopedic Specialists, the largest independent physician-owned, physician-led medical practice in San Diego, continues its growth in San Diego and Riverside Counties by merging Thomas W. Harris, MD’s worker’s compensation medical practice. Additionally, the esteemed group proudly welcomes two new exceptional physicians, Pascual Dutton, MD, and Scot Youngblood, … Read more
DENVER, July 21, 2023 /PRNewswire/ — ViewRay, Inc. (the “Company”) (Nasdaq: VRAY) announced today that on July 17, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”). Nasdaq has determined that due to the Company’s voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code, and … Read more
Cette autorisation de mise sur le marché remplace l’autorisation de mise sur le marché conditionnelle qui avait été accordée au médicament et est la première pour Novavax dans l’Union européenne L’autorisation de mise sur le marché inclut l’utilisation de Nuvaxovid™ en tant que série primaire chez les adolescents âgés de 12 ans et plus et comme rappel chez … Read more
Data Uncovers New Gene Signature to Help Understand Persistence in CAR T-cells PLEASANTON, Calif., July 5, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that its single-cell genomic technologies were used in a study published in the journal Nature Medicine about new gene signatures that explain why some … Read more
Cyltezo® (adalimumab-adbm) expands treatment options for patients across multiple chronic inflammatory diseases Cyltezo is the only adalimumab biosimilar with Phase III comparative clinical studies in rheumatoid arthritis, plaque psoriasis and Crohn’s disease RIDGEFIELD, Conn., July 1, 2023 /PRNewswire/ — Boehringer Ingelheim announced today that Cyltezo® (adalimumab-adbm), a U.S. Food and Drug Administration (FDA)-approved Interchangeable biosimilar to Humira® … Read more
Conference Call to be Held Today at 4:30pm ET SAN DIEGO, June 28, 2023 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today reported financial results for its fiscal year ended March 31, 2023 and provided an update on recent … Read more